Daniel Rubin is an Endocrinology/Metabolic physician affiliated with Temple University. OpenAlex indexes 90 publications with 1,918 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 N Broad St
Philadelphia, PA 191405103
Telephone
215-707-4600Registry record last updated 13 Apr 2018.
Clinical trials
- Readmission Prevention Pilot Trial in Diabetes Patients
Sponsor: Temple University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
45.1%GLP-1 receptor agonist23.9%Mounjaro44%Trulicity35%Ozempic21%Part D<11 patientsInsulin Analog7.7%Lantus Solostar100%Part D≥18 patients+ 2 more classes in this area
Hormonal (systemic)
32.5%l-Thyroxine25%Levothyroxine Sodium53%Synthroid47%Part D≥22 patientsThyroid Hormone Synthesis Inhibitor5.1%Methimazole100%Part D<11 patients+ 1 more class in this area
Cardiovascular
15.4%Statin8.8%Atorvastatin Calcium61%Rosuvastatin Calcium39%Part D<11 patientsACE inhibitor6.6%Lisinopril100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2015–2024 per NIH RePORTER. The latest:
- Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes
Temple Univ of the Commonwealth
FY2024$514,370R01DK122073 - Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes
Temple Univ of the Commonwealth
FY2023$548,401R01DK122073 - Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes
Temple Univ of the Commonwealth
FY2022$565,450R01DK122073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
Cleveland Clinic Journal of Medicine
2024 - Disparities in Shared Decision-Making Research and Practice: The Case for Black American Patients
The Annals of Family Medicine
2023 - Hospital Readmission Risk and Risk Factors of People with a Primary or Secondary Discharge Diagnosis of Diabetes
Journal of Clinical Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Criner, MD
Temple University
Deborah Crabbe, MD
Temple University
Terry Heiman-Patterson, MD
Temple University
Michel Pontari, MD
Temple University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”